Metabolic biomarkers can predict mortality in the ICU

A metabolic profile of intensive care unit (ICU) patients based on biomarkers of four metabolites can be used to accurately predict mortality, according to a new study.

"Existing models for predicting mortality in the ICU may not always be accurate and they can also be cumbersome to use," said researcher Angela J. Rogers MD, MPH, Instructor in Medicine at Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School in Boston. "Levels of lactate, a metabolite from the carbohydrate pathway, are an established biomarker for ICU mortality. Using metabolomics, the scientific study of chemical processes involving metabolites [molecules that are involved or are the product of important cellular processes], we were able to identify several novel biomarkers for predicting mortality in ICU patients and create a network of these metabolites that was highly associated with mortality in two independent populations."

The results of the study will be presented at the ATS 2013 International Conference.

In the study, from 90 ICU patients from the Brigham and Women's Hospital Registry of Critical Illness, with (SIRS), sepsis, or sepsis/acute (ARDS) were tested for the presence of 411 metabolites. These metabolites were analyzed for possible associations with 28-day mortality using a statistical model that adjusted for age, race, gender, malignancy status, and Acute Physiologic and Chronic (APACHE) score.

Of 90 enrolled patients, 30 died by Day 28. Before statistical adjustments were made, a total of 59 metabolites were differentially expressed in survivors and patients who died. These were tested in an independent cohort of 150 patients with sepsis participating in the Community Acquired Pneumonia & Sepsis Outcome Diagnostics (CAPSOD) study. 34 of the individual metabolites were associated with death in that cohort as well.

A final predictive model was created using a statistical model, Bayesian Networks, and included five metabolites: sucrose, and mannose from the carbohydrate pathway and arginine, methionine, and beta-hydroxyisovalerate amino acids. The network was highly associated with mortality in both populations.

"We were impressed with the profound metabolic derangements that were associated with death in two separate cohorts of critically ill patients," said Dr. Rogers. "Because these results replicate well in two populations, it suggests that measuring plasma metabolites may be an important tool for identifying patients at highest risk for death in the ICU."

add to favorites email to friend print save as pdf

Related Stories

Differences in sepsis care identified in europe, U.S.

Oct 26, 2012

(HealthDay)—Despite differences in processes of care and raw mortality for patients with severe sepsis and septic shock in the United States and Europe, after adjustment, mortality rates are similar, according ...

Recommended for you

US hunts contacts of seriously ill Ebola patient

59 minutes ago

US health officials scoured the Dallas area Wednesday for people—including schoolchildren—who came in contact with a Liberian man who was diagnosed with Ebola, as it emerged a hospital mix-up saw him initially turned ...

Australia lifts Ebola donation to $16 million

1 hour ago

Australia more than doubled its donation to the fight against Ebola in West Africa to 18 million Australian dollars ($16 million) on Thursday, but resisted demands to send personnel.

UN says Syria vaccine deaths was an NGO 'mistake'

13 hours ago

The recent deaths of Syrian children after receiving measles vaccinations was the result of a "mistake" by a non-governmental partner who mixed in a muscle relaxant meant for anesthesia, a spokesman for the U.N. secretary-general ...

First US child dies from enterovirus D68

13 hours ago

A child in the northeastern US state of Rhode Island has become the first to die from an ongoing outbreak of a respiratory virus, enterovirus D68, health officials said Wednesday.

User comments